Senegal Private Health Sector Assessment: Selected Health Products and Services
Total Page:16
File Type:pdf, Size:1020Kb
SENEGAL PRIVATE HEALTH SECTOR ASSESSMENT: SELECTED HEALTH PRODUCTS AND SERVICES January 2016 This document was produced for review by the United States Agency for International Development. It was prepared by Bettina Brunner, Jeffrey Barnes, Andrew Carmona, Arsène Kpangon, Pamela Riley, Erin Mohebbi, and Leslie Miles for the Strengthening Health Outcomes through the Private Sector (SHOPS) project. Recommended Citation: Brunner, Bettina, Jeffrey Barnes, Andrew Carmona, Arsène Kpangon, Pamela Riley, Erin Mohebbi, and Leslie Miles. 2016. Senegal Private Health Sector Assessment: Selected Health Products and Services. Bethesda, MD: Strengthening Health Outcomes through the Private Sector Project, Abt Associates. Download copies of SHOPS publications at: www.shopsproject.org Cooperative Agreement: GPO-A-00-09-00007-00 Submitted to: Marguerite Farrell, AOR Bureau of Global Health Global Health/Population and Reproductive Health/Service Delivery Improvement United States Agency for International Development Abt Associates Inc. 4550 Montgomery Avenue, Suite 800 North Bethesda, MD 20814 Tel: 301.347.5000 Fax: 301.913.9061 www.abtassociates.com In collaboration with: Banyan Global • Jhpiego • Marie Stopes International Monitor Group • O’Hanlon Health Consulting SENEGAL PRIVATE HEALTH SECTOR ASSESSMENT: SELECTED HEALTH PRODUCTS AND SERVICES DISCLAIMER The authors’ views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States government. TABLE OF CONTENTS Acronyms .......................................................................................................................... vii Acknowledgments ............................................................................................................. xi Executive Summary ......................................................................................................... xiii 1 Background .................................................................................................................. 1 1.1 Health Sector Gains and Challenges ......................................................................... 2 1.2 Health Strategy in Senegal ........................................................................................ 3 1.2.1 United States Government Strategy in Senegal ................................................ 3 1.3 Purpose and Scope of the Private Sector Assessment .............................................. 4 1.4 Overview of the Report .............................................................................................. 4 2 Methodology ................................................................................................................. 6 2.1 Plan ........................................................................................................................... 6 2.2 Learn ......................................................................................................................... 6 2.3 Analyze ..................................................................................................................... 7 2.4 Share ........................................................................................................................ 7 2.5 Act ............................................................................................................................ 7 2.6 Key Concepts and Terms .......................................................................................... 7 3 The Health Sector in Senegal ...................................................................................... 9 3.1 Overview ................................................................................................................... 9 3.1.1 Size and Structure of the Private Health Sector .............................................. 10 3.2 Key Stakeholders in the Private Health Sector ........................................................ 10 3.2.1 Private For-Profit Sector ................................................................................. 10 3.2.2 Nonprofit Sector .............................................................................................. 10 3.2.3 Human Resources for Health .......................................................................... 12 Civil Society, Regulatory Bodies, and Government StakehoLders ........................... 13 4 Service Provision in the Private Health Sector ........................................................ 15 4.1 General Overview of Trends in Private Sector Provision ......................................... 15 4.2 Family Planning Service Provision ........................................................................... 17 4.3 MNCH Service Provision ......................................................................................... 18 4.4 Provision of HIV and AIDS Services ........................................................................ 20 4.5 Service provision in Malaria ..................................................................................... 21 4.6 Service Provision in Nutrition ................................................................................... 21 4.7 Increasing Demand in the Private Health Sector ..................................................... 23 5 Access to Essential Pharmaceutical and Medical Commodities ............................ 27 5.1 Overview and Structure of the Supply Chain in Senegal .......................................... 27 5.2 Key Government Agencies Involved in Pharmaceutical Supplies ............................ 28 5.3 Commercial Wholesalers, Importers, and Pharmaceutical Retailers ........................ 30 5.4 Accessibility and Pricing of Drugs ............................................................................ 32 5.5 Supply and Access to Medical Commodities ........................................................... 33 ii 5.5.1 FP and MNCH Commodities ........................................................................... 35 5.5.2 HIV and AIDS, Anti-Malarial, and Nutrition Commodities ................................ 38 6 Health Financing in Senegal...................................................................................... 39 6.1 Trends in Supply-Side Health Finance..................................................................... 40 6.2 Trends in Demand-Side Health Finance .................................................................. 41 7 Policy Landscape for the Provision of Private Health Services ............................. 43 7.1 Regulations Influencing the Private Health Sector ................................................... 43 7.2 Public-Private Partnerships in Health ...................................................................... 46 7.3 Current Public-Private Partnerships ................................................................... 47 7.4 Corporate Participation in Health ....................................................................... 48 7.4.1 Corporate Social Responsibility ...................................................................... 48 7.4.2 Worksite Health Programs .............................................................................. 49 8 Role of mHealth in Senegal ....................................................................................... 50 9 Challenges and Recommendations .......................................................................... 52 9.1 Service Delivery Challenges and Recommendations ............................................... 52 9.1.1 Service Delivery Challenges ........................................................................... 52 9.1.2 Service Delivery Recommendations ............................................................... 53 9.1.3 Service Delivery Recommendations by Health Area ....................................... 54 9.2 Demand Challenges and Recommendations ........................................................... 55 9.2.1 Demand Challenges ....................................................................................... 55 9.2.2 Demand Recommendations ............................................................................ 55 9.3 Supply Challenges and Recommendations ............................................................. 56 9.3.1 Supply Challenges .......................................................................................... 56 9.3.2 Supply Recommendations .............................................................................. 56 9.4 Health Financing Challenges and Recommendations .............................................. 57 9.4.1 Health Financing Challenges .......................................................................... 57 9.4.2 Health Financing Recommendations .............................................................. 58 9.5 Policy Environment Challenges and Recommendations .......................................... 59 9.5.1 Policy Environment Challenges ...................................................................... 59 9.5.2 Policy Environment RecomMendations ........................................................... 59 9.5.3 mHealth Challenges ....................................................................................... 61 9.5.4 mHealth Recommendations ............................................................................ 61 10 Conclusion ................................................................................................................